SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
仙林AK47
Lv5
1375 积分
2022-03-03 加入
最近求助
最近应助
互助留言
Anlotinib plus benmelstobart and chemotherapy are effective in ES-SCLC
8天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
15天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
15天前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
17天前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
17天前
已完结
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials
18天前
已完结
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials
18天前
已完结
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
18天前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
18天前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
18天前
已完结
没有进行任何应助
不全,缺少Protocol
15天前
不是全文
1个月前
文章不对
3个月前
自己找到了【积分已退回】
8个月前
感谢
8个月前
附件不全,希望有protocol
8个月前
重新下载【积分已退回】
10个月前
不是附件
10个月前
没有附件【积分已退回】
10个月前
感谢
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论